BPC-157 for Plantar Fasciitis
How It Works
Promotes angiogenesis, increases growth factor expression, and has cytoprotective effects.
Research Evidence
Multiple animal studies demonstrate efficacy. Human data is anecdotal but extensive.
Dosing Protocol
250-500mcg daily, subcutaneously or orally (stable arginine salt), for 4-8 weeks.
Important Considerations
- !No human clinical trials
- !WADA banned
- !Gray market quality concerns
- !Consult healthcare provider before use
- !Quality sourcing is critical
Frequently Asked Questions
Does BPC-157 work for plantar fasciitis?
Multiple animal studies demonstrate efficacy. Human data is anecdotal but extensive. Research level: Animal studies show promise.
How does BPC-157 help with plantar fasciitis?
Promotes angiogenesis, increases growth factor expression, and has cytoprotective effects.
What is the BPC-157 dosage for plantar fasciitis?
250-500mcg daily, subcutaneously or orally (stable arginine salt), for 4-8 weeks.
Is BPC-157 safe for plantar fasciitis?
Key considerations: No human clinical trials. WADA banned. Gray market quality concerns. Consult healthcare provider before use. Quality sourcing is critical. Always consult a healthcare provider.
How long until BPC-157 works for plantar fasciitis?
Results vary by individual and condition severity. Most users report initial effects within 2-4 weeks, with full benefits developing over 8-12 weeks of consistent use.